Trial Profile
Multi-center, prospective, controlled, randomized, single-blinded study to evaluate the efficacy of vibrotactile neuro-feedback additionally to intake of Ginkgo biloba special extract EGb 761® for the treament of presby vertigo.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2019
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Vertigo
- Focus Therapeutic Use
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 16 Jul 2018 Status changed from recruiting to completed.
- 30 Sep 2016 New trial record